Imaging & Diagnostics

Can Metabolic Imaging Predict CAR T-Cell Therapy Success?
Imaging & Diagnostics Can Metabolic Imaging Predict CAR T-Cell Therapy Success?

The clinical landscape for treating aggressive large B-cell lymphoma has undergone a radical transformation with the advent of Chimeric Antigen Receptor T-cell therapy, yet the ability to accurately forecast which patients will achieve long-term remission remains an elusive goal for many oncology

How Can We Secure the Global Supply of Medical Isotopes?
Imaging & Diagnostics How Can We Secure the Global Supply of Medical Isotopes?

The global medical community currently stands at a transformative crossroads where the successful development of radioligand therapies faces the stark reality of a strained and aging production infrastructure. As of 2026, the Third International Workshop on Medical Radioisotope Supply has

New No-Code Platform Advances OCT Imaging and Diagnostics
Imaging & Diagnostics New No-Code Platform Advances OCT Imaging and Diagnostics

The rapid evolution of Optical Coherence Tomography has transformed it from a niche ophthalmological tool into a versatile powerhouse capable of revealing the microscopic secrets of human tissue across various medical specialties. While clinicians have long relied on this technology to map retinal

Can Butterfly’s AI Chip Make Ultrasound for Everyone?
Imaging & Diagnostics Can Butterfly’s AI Chip Make Ultrasound for Everyone?

Chloe, thanks for having me. I’ve spent my career building robotics and IoT systems that survive chaos—ambulances, rural clinics with flickering power, and ORs where seconds matter. Ultrasound-on-a-chip is a watershed moment because it collapses three barriers at once: cost, portability, and

Radiopharmaceuticals Market to Reach $15.2B by 2035
Imaging & Diagnostics Radiopharmaceuticals Market to Reach $15.2B by 2035

Surging oncology and cardiology caseloads have turned nuclear medicine from a niche toolkit into a frontline engine for precise diagnosis and targeted therapy across health systems worldwide, and that shift is showing up in the numbers. The global radiopharmaceuticals market was projected to expand

No Surprises Act Arbitration Is Driving Up Healthcare Costs
Imaging & Diagnostics No Surprises Act Arbitration Is Driving Up Healthcare Costs

While patients are no longer receiving terrifying medical bills for thousands of dollars after an emergency, the hidden machinery of federal arbitration is quietly pushing the entire nation’s insurance premiums into a new and dangerous stratosphere. The No Surprises Act (NSA) was heralded as a

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later